Connect with us

Business

Asia-Pacific Healthcare Crisis: Burnout, Demand and an 18-Month Warning

Published

on

Asia-Pacific Healthcare Crisis: Burnout, Demand and an 18-Month Warning
  • A Bain & Company report drawing on surveys of 600 doctors and 6,300 consumers across Asia-Pacific finds the region’s healthcare systems under simultaneous pressure from physician burnout and rising consumer expectations. One in five doctors are considering leaving their jobs, while 84% of patients demand greater convenience and 95% want a single point of contact for their care.
  • AI adoption is widely supported by both patients and clinicians but organisational readiness remains limited, with one in three doctors saying their institution is unprepared to deploy it at scale. Bain identifies an 18-month window for providers and insurers to act, emphasising clinician engagement and coordinated care models as prerequisites for sustainable change.

A wave of physician burnout is colliding with a surge in consumer demand across Asia-Pacific’s healthcare systems, according to a major new report from global consultancy Bain & Company, which warns that the region’s providers, insurers and pharmacies have roughly 18 months to adapt before losing ground to faster-moving competitors.

Key takeaways

  • One in five Asia-Pacific doctors are considering leaving their jobs, driven by heavy workloads and lack of recognition rather than pay, threatening the region’s already thin physician supply.
  • Patients are behaving like consumers, with 84% demanding more convenience, 95% wanting a single point of contact for their care, and nearly 60% shifting to alternative settings like telehealth, retail clinics and home-based visits.
  • Appetite for AI in healthcare is high among both patients and doctors, but one in three physicians say their organisation isn’t ready to deploy it at scale, leaving an 18-month window for providers and insurers to adapt before losing ground.

The report, Bain’s fourth biennial study of frontline healthcare trends in the region, draws on surveys of 600 doctors in Australia and the Philippines and 6,300 consumers across nine countries, conducted in December 2025. Its authors describe a system caught between two forces moving in opposite directions: patients who increasingly behave like demanding consumers, and a clinical workforce that is stretched to its limit.

A Widening Gap Between Supply and Demand

The tension, researchers argue, stems from a structural mismatch. Asia-Pacific is home to roughly 60% of the world’s population and carries an outsized share of global disease burden, yet the region accounts for only about 22% of worldwide healthcare spending. Physician density remains thin, excluding China, the report puts the average at under one doctor per 1,000 people, far below the World Health Organization’s recommended minimum of 2.5.

Against that backdrop, long wait times have topped the list of consumer complaints for four consecutive Bain surveys, a pattern the report says holds true regardless of whether a country’s system is public or private, wealthy or developing. High out-of-pocket costs compound the problem: fewer than 70% of patients with chronic conditions reported keeping up with regular check-ups, with cost cited as the main deterrent.

Physicians on the Edge

Doctors, meanwhile, are signalling they’ve had enough. Roughly 20% of physicians surveyed said they are actively weighing a move to a different organisation, and about 30% believe recruitment and retention have worsened since 2023. The report attributes this primarily to heavy workloads and a lack of professional recognition rather than pay. Doctors in both mature markets like Australia and emerging ones like the Philippines ranked career development and access to modern tools above compensation as priorities, yet only about 30% said they were satisfied on either front.

The stakes of ignoring this trend are high, the report suggests: physicians who feel engaged in strategic decisions at their organisations reported workplace advocacy scores up to 36 points higher than colleagues who don’t, a gap researchers linked to broader outcomes in patient care and safety.

Advertisement

Patients Are Acting Like Consumers

On the demand side, the report documents a marked shift toward consumer-style healthcare behaviour. The vast majority of respondents, 84%, said they now expect more convenience from the healthcare system than they did two years ago, and 71% want doctors to be reachable through messaging apps or email rather than waiting for scheduled visits. Nearly 70% said they had used AI tools to help interpret a diagnosis or treatment plan.

Preventive care usage has also jumped, with 60% of consumers reporting regular check-ups and screenings in 2025, up from 47% two years earlier, a trend led by China, where 76% of respondents said they get routine screenings.

Spending patterns reflect the same shift: consumers reported increasing what they spend across every category of health and wellness, with nutrition supplements, fitness, and oral healthcare showing the sharpest gains.

Care Is Moving Outside the Hospital

Consumers are also voting with their feet when it comes to where they receive treatment. Close to 60% now use alternative care settings such as walk-in clinics, home-based visits, telehealth or wearable devices, a significant jump from intent levels measured in 2019. The preferred format varies widely by market: retail clinics dominate in Malaysia and Australia, home-based care leads in India and Vietnam, and telehealth is the top choice in China and Singapore, where usage has climbed to 61% of consumers, up 37 percentage points since 2019.

Advertisement

By contrast, telehealth adoption in India has fallen sharply, dropping to just 10% penetration as the market’s largely cash-based payment structure limits insurer-driven incentives to use virtual care.

Surgeons surveyed said they would like to perform far more procedures in ambulatory surgical settings than they currently do, citing patient preference and better access to modern equipment as key drivers.

Fragmentation Frustrates Patients and Doctors Alike

A recurring theme in the report is fragmentation. Half of consumers said they were referred to multiple providers before receiving an accurate diagnosis, and more than 40% received conflicting advice from different clinicians. For patients managing chronic illness, more than half said they had to see multiple doctors just to get their needs met.

Clinicians feel the strain from the other side: roughly one in three doctors reported significant inefficiency at their organisation, and about 40% said they regularly perform repetitive administrative tasks that could be automated.

Advertisement

The result, according to Bain, is overwhelming demand for simplification. 95% of consumers said they want a single point of contact to manage their care, up sharply from 70% in 2019. Yet access to primary care physicians, who are seen by most consumers as the natural candidate for that role, remains inconsistent; roughly a quarter of the region’s population has no primary care doctor at all, with gaps particularly pronounced in Malaysia, Hong Kong, Indonesia and China.

AI: Wanted, But Not Fully Trusted or Ready

Artificial intelligence emerges in the report as both the most promising fix and the area of greatest organisational weakness. Nearly three-quarters of Asia-Pacific consumers said they’re comfortable with at least one AI healthcare application, a notably higher comfort level than researchers found among American consumers in a parallel study. Support is strongest for AI that assists clinicians, such as automated documentation or decision support, rather than AI that replaces human interaction entirely, though more than 35% of respondents said they’d accept AI-only call centres or diagnostic tools.

Doctors broadly share this cautious optimism, hoping AI will ease administrative burdens while worrying it could erode the doctor-patient relationship, a concern the report says mirrors sentiment in the US and UK.

But readiness lags behind appetite. About one in three doctors said their organisation isn’t prepared to deploy AI at scale, citing unclear strategy, inadequate training and insufficient involvement from clinical staff. Even basic digital infrastructure such as workforce management systems and revenue cycle tools remains underused, the report found, even in a relatively advanced market like Australia.

Advertisement

Some organisations are further along. The report cites Apollo Hospitals’ clinical decision-support platform, which covers 1,300 conditions and is maintained by more than 500 in-house clinicians, and Singapore General Hospital’s AI-driven perioperative chatbot, which researchers say has saved an estimated 660 doctor hours a year across 25,000 patients. Ping An Good Doctor, meanwhile, reportedly uses AI agents to handle up to 4 million consultation requests daily, cutting per-doctor service costs by roughly half.

Five Priorities for Industry Leaders

Bain’s authors, partners Vikram Kapur, Alex Boulton, Lucy d’Arville and Dhruv Sukhrani, along with practice senior manager Monica Pinto Basto, lay out five strategic priorities for healthcare leaders in the region: building a trusted single point of coordination for patients; redesigning care journeys around the interactions that matter most to patient loyalty, particularly billing; adopting value-based care models tied to outcomes rather than volume; treating AI deployment as a full business transformation rather than a bolt-on feature; and prioritising clinician engagement as a precondition for successful change.

The report singles out billing and coverage disputes as the single biggest driver of dissatisfied patients across the region, and warns insurers in particular that failing to modernise these interactions risks accelerating the shift toward other players such as providers, retailers, and digital platforms, who are moving to claim the “trusted coordinator” role in patients’ healthcare journeys.

The Bottom Line

Bain’s overarching message is that structural pressure on Asia-Pacific’s healthcare systems will not ease on its own, and that AI, while promising, cannot substitute for organisational change. “Technology-driven advantages cannot scale without the workforce,” the report concludes, arguing that organisations willing to invest in clinician trust and involve doctors as partners in AI-driven transformation stand to gain the most, both from a more engaged workforce and from patients who, once satisfied, tend to stay loyal and spend more.

Advertisement

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

XPO Stock: Big Gains From Small Improvements In Its Operating Ratio (NYSE:XPO)

Published

on

XPO Stock: Big Gains From Small Improvements In Its Operating Ratio (NYSE:XPO)

This article was written by

Robert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options, mainly covered calls and collars with long stocks. He is a freelance writer, and his projects include a website that provides information for new and intermediate-level mutual fund investors. A resident of Airdrie, Alberta, Canada, Robert has earned Bachelor of Arts and Master of Business Administration (MBA) degrees.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

WestJet flight attendants go on strike after talks fall through

Published

on


WestJet flight attendants go on strike after talks fall through

Continue Reading

Business

Equity mutual funds gained up to 6% in last week of July. Check top 15 with over 3% gain

Published

on

The Economic Times

Equity mutual funds delivered gains up to six percent in the last week of July. Top performers included technology and transportation sector funds which saw significant returns. SBI Technology Opp Fund and Aditya Birla SL Digital India Fund led the gains. ICICI Pru Transportation and Logistics Fund also performed well during this period. Several other tech and logistics funds also registered positive returns.

Continue Reading

Business

Ukrainian drones kill two in Russia, strike Wildberries warehouse, governors say

Published

on


Ukrainian drones kill two in Russia, strike Wildberries warehouse, governors say

Continue Reading

Business

4 Hyperscalers, One Message: The AI Trade Isn't Over

Published

on

4 Hyperscalers, One Message: The AI Trade Isn't Over

4 Hyperscalers, One Message: The AI Trade Isn't Over

Continue Reading

Business

Hungarian companies pivot after Orban’s allies lose political influence

Published

on


Hungarian companies pivot after Orban’s allies lose political influence

Continue Reading

Business

Mutual fund NFOs: 7 new funds will open for subscription this week. Check dates

Published

on

The Economic Times

Seven mutual fund NFOs from Kotak, Motilal Oswal, AlphaGrep, JioBlackRock, Edelweiss and Franklin India will open for subscription this week. The offers span index funds, ETFs, a fund of funds and a short-duration debt scheme, with minimum investments ranging from Rs 10 to Rs 5,000.

Continue Reading

Business

Mcap of nine of top-10 most valued firms jumps Rs 2.51 lakh cr; Bajaj Finance biggest winner

Published

on

Mcap of nine of top-10 most valued firms jumps Rs 2.51 lakh cr; Bajaj Finance biggest winner
The combined market valuation of nine of the top-10 most-valued firms jumped Rs 2.51 lakh crore last week, with Bajaj Finance emerging as the biggest winner, in tandem with a positive trend in equities.

Last week, the BSE benchmark Sensex climbed 2,034.87 points, or 2.67 per cent, and the NSE Nifty surged 616.15 points, or 2.59 per cent.

“Markets staged a strong rebound during the week, snapping their recent losing streak as easing crude oil prices, improving geopolitical sentiment, encouraging Q1 FY27 earnings, and renewed foreign institutional investor (FII) buying lifted risk appetite,” Ajit Mishra – SVP, Research, Religare Broking Ltd, said.

While Reliance Industries, Bharti Airtel, HDFC Bank, ICICI Bank, State Bank of India, Tata Consultancy Services (TCS), Bajaj Finance, Larsen & Toubro, and Life Insurance Corporation of India (LIC) were the gainers from the top-10 pack, Hindustan Unilever emerged as the only laggard.

Advertisement

The market valuation of Bajaj Finance surged Rs 80,345.97 crore to Rs 7,10,817.51 crore, the most among the top-10 firms. Shares of NBFC Bajaj Finance on Friday ended over 8 per cent higher after the firm reported a 28 per cent year-on-year rise in consolidated profit after tax (PAT) for the June quarter of FY27.


Bharti Airtel’s valuation soared Rs 44,959.5 crore to reach Rs 12,30,005.63 crore.
The market valuation of TCS jumped Rs 40,414.03 crore to Rs 8,55,894.78 crore and that of Reliance Industries climbed Rs 39,447.35 crore to Rs 17,69,108.79 crore.The market capitalisation (mcap) of Larsen & Toubro rallied Rs 21,096.8 crore to Rs 5,41,844.69 crore and that of State Bank of India edged higher by Rs 10,845.97 crore to Rs 9,47,799.81 crore.

HDFC Bank’s mcap advanced Rs 8,164.73 crore to Rs 11,52,150.63 crore.

The valuation of LIC went up Rs 4,427.49 crore to Rs 5,37,435.05 crore and that of ICICI Bank climbed Rs 1,660.37 crore to Rs 10,29,878.30 crore.

However, the mcap of Hindustan Unilever declined Rs 10,326.46 crore to Rs 4,93,602.13 crore.

Advertisement

Reliance Industries remained the most valued firm, followed by Bharti Airtel, HDFC Bank, ICICI Bank, State Bank of India, TCS, Bajaj Finance, Larsen & Toubro, LIC, and Hindustan Unilever.

Continue Reading

Business

FPIs reverse 4-month selling trend with Rs 20,200 cr inflow in July

Published

on

FPIs reverse 4-month selling trend with Rs 20,200 cr inflow in July
After four straight months of selling, foreign investors turned net buyers of Indian equities in July, pumping in Rs 20,200 crore, aided by attractive valuations, improving corporate earnings and easing global headwinds.

The latest inflow marks a sharp reversal from the preceding months, when Foreign Portfolio Investors (FPIs) withdrew Rs 49,340 crore in June, Rs 32,963 crore in May, Rs 60,847 crore in April and a massive Rs 1.17 lakh crore in March, according to data from the Central Depository Services (India) Ltd (CDSL).

Prior to the four-month selling spree, FPIs had invested Rs 22,615 crore in Indian equities in February.

Despite the turnaround in July, foreign investors have pulled out a net Rs 2.54 lakh crore from Indian equities so far in 2026, way more than the Rs 1.66 lakh crore withdrawn during the whole of 2025.

Advertisement

Market experts attributed the renewed foreign investor interest to relatively stable domestic markets, reasonable large-cap valuations, improving earnings prospects and a more favourable global environment.


V K Vijayakumar, Chief Investment Strategist at Geojit Investments, said excessive volatility in markets such as South Korea and Taiwan, coupled with concentration risk in the “chip trade”, is prompting FPIs to look for relatively stable markets like India.
The stability of the rupee and fair valuations of India’s large-cap stocks are other factors facilitating renewed FPI inflows into the country, he added.Vedant Gupte, Co-Founder and CEO of investment platform Trackk, said improving earnings prospects also strengthened investor sentiment, with June quarter results showing signs of recovery across key sectors.

IT stocks, in particular, witnessed a sharp re-rating as better-than-expected earnings helped ease concerns over the impact of artificial intelligence on the sector’s growth prospects, he said.

At the same time, easing pressure from the US dollar and expectations that US interest rates are near their peak have improved the investment environment for emerging markets, Gupte added.

Foreign investor interest was not limited to equities, with the debt market continuing to attract significant inflows during the month.

Advertisement

FPIs invested Rs 29,212 crore in debt through the general route and another Rs 3,033 crore through the fully accessible route in July.

Going forward, the trajectory of foreign flows is likely to be influenced by both global developments and domestic triggers.

Pabitro Mukherjee, Deputy Vice President-Research at Bajaj Broking, said investors in the coming month will closely track crude oil price movements and developments in the ongoing US-Iran geopolitical tensions.

On the domestic front, the Q1FY27 earnings season and the RBI’s monetary policy scheduled for August 5 will remain in focus, he added.

Advertisement
Continue Reading

Business

Life after Orban: Hungary Inc digs in as new political era takes hold

Published

on


Life after Orban: Hungary Inc digs in as new political era takes hold

Continue Reading

Trending

Copyright © 2025